Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.6.3.1 (
Mg2+-ATPase
)
1,484
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We found that isolated gastric vesicles contain a novel Mg2+-ATP-dependent phospholipid translocation (
flippase
) activity. Fluorescence analogue of phosphatidylcholine, 2-(12-(7-nitrobenz-2-oxa-1, 3-diazol-4-yl)amino)dodecanoyl-1-hexadecanoyl-sn-glycero-3- phosphocholine, was ATP-dependently translocated from the outer (cytosolic) to inner (luminal) leaflet of the lipid membrane bilayer of hog gastric vesicles. The translocation was saturable and depended on time and the ATP concentration (Km = 3.1 microM). The basal
Mg2+-ATPase
activity of gastric vesicles in the absence of K+ showed high (Km = 1.6 microM) and low (Km = 80 microM) affinities for ATP, indicating that the present
flippase
activity is driven mostly by the high affinity
Mg2+-ATPase
activity. It required Mg2+ but not K+.
Verapamil
, which is an inhibitor of mouse mdr2 phosphatidylcholine
flippase
, did not inhibit the present
flippase
activity. Isolated sarcoplasmic reticulum vesicles that contain Ca2+-ATPase did not show any
flippase
activity. Fluorescence analogues of phosphatidylserine and phosphatidylethanolamine were similarly translocated by the gastric
flippase
. These phospholipid
flippase
activities were inhibited by 2-methyl-8-(phenylmethoxy)imidazo[1,2-a]pyridine-3-acetonitrile (SCH 28080) (IC50 = 0.14-0.25 microM), a specific K+-ATPase inhibitor of gastric H+,K+-ATPase rich in gastric vesicles. IC50 value for the SCH 28080-inhibitable
Mg2+-ATPase
activity was about 0.13 microM, indicating that the phospholipid translocation was driven mostly by the SCH 28080-sensitive
Mg2+-ATPase
activity. Possible physiological roles of flippases were discussed in relation with the gastric acid secretory and cytoprotective mechanisms.
...
PMID:The phospholipid flippase activity of gastric vesicles. 909 84